Nektar TherapeuticsNKTRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank64
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-32.83M
↑ 38% vs avg
Percentile
P64
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-53.31M
Historical baseline
PeriodValueYoY Change
TTM$-32.83M-134.4%
2024$-14.00M+89.9%
2023$-138.83M-11.3%
2022$-124.75M-61.6%
2021$-77.18M-20.5%
2020$-64.03M-336873.7%
2019$-19000.00+99.6%
2018$-5.21M+85.7%
2017$-36.43M+8.4%
2016$-39.79M-